Opko Health Director Unloads $396,270 in Stock (OPK)
Opko Health (NYSE:OPK) Director Robert Baron sold 46,730 shares of Opko Health stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $8.48, for a total value of $396,270.40. Following the completion of the sale, the director now directly owns 285,965 shares in the company, valued at approximately $2,424,983. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.
Opko Health (NYSE:OPK) traded up 2.37% during mid-day trading on Friday, hitting $8.63. 2,780,109 shares of the company’s stock traded hands. Opko Health has a 1-year low of $5.30 and a 1-year high of $12.95. The stock has a 50-day moving average of $9.43 and a 200-day moving average of $8.97. The company’s market cap is $3.521 billion.
A number of analysts have recently weighed in on OPK shares. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note to investors on Friday, December 20th. Separately, analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note to investors on Wednesday, December 18th. Finally, analysts at Jefferies Group raised their price target on shares of Opko Health from $10.00 to $11.50 in a research note to investors on Wednesday, November 13th. They now have a “buy” rating on the stock.
OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.